Company page

Cytomed Therapeutics Limited

Cytomed Therapeutics Limited, trading under the ticker GDTC, is a public company based in the United States with a market capitalization of approximately $13.8 million. The company focuses on developing innovative therapeutic solutions in the healthcare sector. As a publicly traded entity, Cytomed is subject to the regulatory requirements of the American market.